Product of MicroPort<sup>®</sup> EP Completed First Clinical Case Observation

On December 23, Shanghai MicroPort EP MedTech Co ("MicroPort® EP")'s new product, the Cardiovascular Catheter Sheath and the Accessories, completed its first clinical case observation in the General Hospital of Shenyang Military Region. Compared with similar imported products, the surgeon's evaluation of the product was very good.
 
The product is independently researched and developed by MicroPort® EP, and it's an essential for the catheter ablation of atrial fibrillation surgery, guiding radiofrequency catheter ablation and mapping catheter to a desired location in the surgery. This time's clinical observation mainly studies the safety and effectiveness of the product, and the achievement indicates MicroPort® EP takes a step forward for providing a systematic solution for the treatment of complex arrhythmia.